نتایج جستجو برای: metastatic melanoma

تعداد نتایج: 136184  

Journal: :Molecular cancer therapeutics 2015
David S Hill Neil D P Robinson Matthew P Caley Mei Chen Edel A O'Toole Jane L Armstrong Stefan Przyborski Penny E Lovat

Metastatic melanoma remains incurable, emphasizing the acute need for improved research models to investigate the underlying biologic mechanisms mediating tumor invasion and metastasis, and to develop more effective targeted therapies to improve clinical outcome. Available animal models of melanoma do not accurately reflect human disease and current in vitro human skin equivalent models incorpo...

Journal: :Case reports in ophthalmological medicine 2016
Hiren Mandaliya Nandini Singh Sanila George Mathew George

Metastatic choroid melanoma is a highly malignant disease with a limited life expectancy. The liver is the most common site for metastasis of uveal melanoma followed by lung, bone, skin, and subcutaneous tissue. Metastasis from choroidal melanoma usually occurs within the first five years of treatment for primary tumours. Metastatic choroid melanoma to the spine/vertebrae is extremely rare. We ...

2017
Omar Bari Philip R Cohen

Tumoral melanosis is a form of completely regressed melanoma that usually presents as darkly pigmented lesions suspicious for malignant melanoma. Histology reveals dense dermal and subcutaneous infiltration of melanophages. Pembrolizumab is an antibody directed against programmed death receptor-1 (PD1) and is frontline treatment for advanced melanoma. An 81-year-old man with metastatic melanoma...

2016
Shinji Iizuka Christopher Abdullah Matthew D. Buschman Begoña Diaz Sara A. Courtneidge

Metastatic cancer cells are characterized by their ability to degrade and invade through extracellular matrix. We previously showed that the Tks adaptor proteins, Tks4 and Tks5, are required for invadopodia formation and/or function in Src-transformed fibroblasts and a number of human cancer cell types. In this study, we investigated the role of Tks adaptor proteins in melanoma cell invasion an...

Journal: :Cancer research 2006
Luana Lugini Paola Matarrese Antonella Tinari Francesco Lozupone Cristina Federici Elisabetta Iessi Massimo Gentile Francesca Luciani Giorgio Parmiani Licia Rivoltini Walter Malorni Stefano Fais

The phenomenon of cell cannibalism, which generally refers to the engulfment of cells within other cells, was described in malignant tumors, but its biological significance is still largely unknown. In the present study, we investigated the occurrence, the in vivo relevance, and the underlying mechanisms of cannibalism in human melanoma. As first evidence, we observed that tumor cannibalism was...

Journal: :Archives of surgery 2004
Nahel Elias Kenneth K Tanabe Arthur J Sober Michele A Gadd Martin C Mihm Barrett Goodspeed A Benedict Cosimi

HYPOTHESIS Completion lymph node dissection (CLND) has usually been recommended after metastatic disease is identified in the sentinel lymph node (SLN) biopsy to eradicate further metastases in nonsentinel nodes. We hypothesized that patients with negative lymph nodes included in the initial SLN specimen have low risk of metastases in the residual draining basin and may not require CLND. DESI...

Journal: :Cancer research 1996
D Marchetti G L Nicolson

Heparanase is an endo-beta-D-glucuronidase whose enzymatic targets are the glycosaminoglycan chains of heparan sulfate proteoglycans (50). Elevated levels of heparanase are associated with the metastatic potential of melanoma cells, and treatment of murine and human melanoma cells with the prototypic neurotrophin nerve growth factor (NGF) increases the production of heparanase by melanoma cells...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2016
Heike Niessner Jennifer Schmitz Ghazaleh Tabatabai Andreas M Schmid Carsten Calaminus Tobias Sinnberg Benjamin Weide Thomas K Eigentler Claus Garbe Birgit Schittek Leticia Quintanilla-Fend Benjamin Bender Marion Mai Christian Praetorius Stefan Beissert Gabriele Schackert Michael H Muders Matthias Meinhardt Gustavo B Baretton Reinhard Dummer Keith Flaherty Bernd J Pichler Dagmar Kulms Dana Westphal Friedegund Meier

PURPOSE Great advances have recently been made in treating patients with metastatic melanoma. However, existing therapies are less effective on cerebral than extracerebral metastases. This highlights the potential role of the brain environment on tumor progression and drug resistance and underlines the need for "brain-specific" therapies. We previously showed that the PI3K-AKT survival pathway ...

2014
Abhisek Swaika Jennifer A Crozier Richard W Joseph

The discovery of BRAF mutations in the majority of patients with metastatic melanoma combined with the identification of highly selective BRAF inhibitors have revolutionized the treatment of patients with metastatic melanoma. The first highly specific BRAF inhibitor, vemurafenib, began clinical testing in 2008 and moved towards a rapid approval in 2011. Vemurafenib induced responses in ~50% of ...

Journal: :World Journal of Surgical Oncology 2007
Ugo Marone Corrado Caracò Simona Losito Antonio Daponte Maria Grazia Chiofalo Stefano Mori Rocco Cerra Luciano Pezzullo Nicola Mozzillo

BACKGROUND Only 2% to 4% of patients with melanoma will be diagnosed with gastrointestinal metastasis during the course of their disease. The most common sites of gastrointestinal metastases from melanoma include the small bowel (35%-67%), colon (9%-15%) and stomach (5%-7%), with a median survival of 6-10 months after surgery, and 18% survival at five years. Metastatic melanoma to the gallbladd...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید